Public-registry site landscape for NCT07735637, a Newly Diagnosed Multiple Myeloma (NDMM) study sponsored by AstraZeneca. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07735637 (registry record) |
| Sponsor | AstraZeneca |
| Condition(s) | Newly Diagnosed Multiple Myeloma (NDMM) |
| Phase | PHASE3 |
| Listed sites | 65 |
| Site countries | United States, Australia, Brazil, Canada, Denmark, France, Germany, Italy, Norway, Poland, Singapore, South Korea |
Eichor generates a preliminary site-risk snapshot for NCT07735637 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →